VEGFD and cancer: Liposomal honokiol exerted a significant inhibitory effect on lymphangiogenesis by downregulation of the level of VEGF‐D in VEGF‐D‐LL/2 cancer cells and interacting neogenesis and formation of LECs directly through the VEGFR‐3 pathway.